BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 9350483)

  • 21. Hyperhomocyst(e)inemia is an important risk factor for vascular disease in subjects with high-molecular weight apo(a) isoforms.
    Delport R; Lingenhel AW; Ubbink JB; Kraft HG
    Cardiovasc J S Afr; 2004; 15(5):207-13. PubMed ID: 15483732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Moderate hyperhomocyst(e)inemia is associated with the presence of coronary artery disease and the severity of coronary atherosclerosis in Koreans.
    Yoo JH; Park JE; Hong KP; Lee SH; Kim DK; Lee WR; Park SC
    Thromb Res; 1999 Apr; 94(1):45-52. PubMed ID: 10213180
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Schmidt AM; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1998 May; 21(5):841-8. PubMed ID: 9589252
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular dysfunction in monkeys with diet-induced hyperhomocyst(e)inemia.
    Lentz SR; Sobey CG; Piegors DJ; Bhopatkar MY; Faraci FM; Malinow MR; Heistad DD
    J Clin Invest; 1996 Jul; 98(1):24-9. PubMed ID: 8690798
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Arteriosclerosis due to homocyst (e) inemia. Failure to reproduce the model in weanling rabbits.
    Donahue S; Struman JA; Gaull G
    Am J Pathol; 1974 Nov; 77(2):167-3. PubMed ID: 4447126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease.
    Kang SS; Wong PW; Malinow MR
    Annu Rev Nutr; 1992; 12():279-98. PubMed ID: 1503807
    [No Abstract]   [Full Text] [Related]  

  • 27. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA; Kohl B; Zumbach MS; Borcea V; Bierhaus A; Henkels M; Amiral J; Fiehn W; Ziegler R; Wahl P; Nawroth PP
    Diabetes Care; 1997 Dec; 20(12):1880-6. PubMed ID: 9405911
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vascular dysfunction in hyperhomocyst(e)inemia. Implications for atherothrombotic disease.
    Stanger O; Weger M; Renner W; Konetschny R
    Clin Chem Lab Med; 2001 Aug; 39(8):725-33. PubMed ID: 11592442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Determinants of plasma homocyst(e)ine in patients with nephrotic syndrome.
    Joven J; Arcelús R; Camps J; Ordóñez-Llanos J; Vilella E; González-Sastre F; Blanco-Vaca F
    J Mol Med (Berl); 2000; 78(3):147-54. PubMed ID: 10868477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
    Yoo JH; Chung CS; Kang SS
    Stroke; 1998 Dec; 29(12):2478-83. PubMed ID: 9836754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute multiple brain infarction in large-artery atherosclerosis is associated with hyperhomocyst(e)inemia.
    Yokote H; Shiraishi A; Shintani S; Shiigai T
    Acta Neurol Scand; 2007 Oct; 116(4):243-7. PubMed ID: 17824903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The oxidant stress of hyperhomocyst(e)inemia.
    Loscalzo J
    J Clin Invest; 1996 Jul; 98(1):5-7. PubMed ID: 8690803
    [No Abstract]   [Full Text] [Related]  

  • 33. Is Hyperhomocyst(e)inemia a humoral predictor of coronary heart disease?
    Virdis A; Ghiadoni L; Versari D; Salvetti G; Pinto S; Favilla S; Taddei S; Salvetti A
    Curr Pharm Des; 2005; 11(17):2187-97. PubMed ID: 16026288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hyperhomocyst(e)inemia and Chlamydia pneumoniae IgG seropositivity in patients with coronary artery disease.
    Stanger OH; Semmelrock HJ; Rehak P; Tiran B; Meinitzer A; Rigler B; Tiran A
    Atherosclerosis; 2002 May; 162(1):157-62. PubMed ID: 11947909
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
    Tan NC; Venketasubramanian N; Saw SM; Tjia HT
    Stroke; 2002 Aug; 33(8):1956-62. PubMed ID: 12154245
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperhomocyst(e)inemia induces multiorgan damage.
    Miller A; Mujumdar V; Shek E; Guillot J; Angelo M; Palmer L; Tyagi SC
    Heart Vessels; 2000; 15(3):135-43. PubMed ID: 11289502
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interrelation of hyperhomocyst(e)inemia, factor V Leiden, and risk of future venous thromboembolism.
    Ridker PM; Hennekens CH; Selhub J; Miletich JP; Malinow MR; Stampfer MJ
    Circulation; 1997 Apr; 95(7):1777-82. PubMed ID: 9107163
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Detection of heterozygotes for recessive alleles. Homocyst(e)inemia: paradigm of pitfalls in phenotypes.
    McGill JJ; Mettler G; Rosenblatt DS; Scriver CR
    Am J Med Genet; 1990 May; 36(1):45-52. PubMed ID: 2185635
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Homocysteine as a risk factor for cardiovascular disease.
    Graham IM
    Trends Cardiovasc Med; 1991 Sep; 1(6):244-9. PubMed ID: 21239303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Homocysteine and vascular dysfunction.
    Lentz SR
    Life Sci; 1997; 61(13):1205-15. PubMed ID: 9324062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.